BIMINI Biotech
Leiden
About BIMINI Biotech
BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging. The company was founded in 2019 and is based in Leiden, The Netherlands.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.3M
- Funding stage: Seed
- Last round: Seed (Jan 2025)
- Website: biminibiotech.nl
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bimini-biotech-64754 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.